Advertisement

Multidrug Abuse and Dependence

  • Marc A. Schuckit
Part of the Critical Issues in Psychiatry book series (CIPS)

Abstract

A review of the epidemiology sections of the prior chapters reveals that most people have had experience with alcohol, nicotine, and at least one illicit substance at some time in their lives.1,2 The consumption of these substances has many implications, especially for drug interactions when two or more pharmacological agents are taken at the same time. The situation becomes even more complex in individuals who are also consuming over-the-counter (OTC) medications and prescription drugs. Each substance has a potential for impacting on how other drugs are absorbed into the body, distributed throughout the tissues, metabolized, and how they impact on organs such as the brain.3

Keywords

Multiple Drug Withdrawal Syndrome Antisocial Personality Disorder Toxic Reaction Illicit Substance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National Household Survey on drug abuse: Population estimates 1997. Rockville, MD: U.S. Department of Health and Human Services, 1998.Google Scholar
  2. 2.
    Johnston, L. D., O’Malley, P. M., & Bachman, J. G. National survey results on drug use front the Monitoring the Future Study, 1975–1997, Vol. I, Secondary School Students. Rockville, MD: National Institute on Drug Abuse, U.S. Department of Health and Human Services, 1998.Google Scholar
  3. 3.
    Schuckit, M. A. A clinical review of the use of anticonvulsive medications in persons with developmental disabilities. Developmental Disabilities: Clinical Insights 2, San Diego Regional Center for the Developmentally Disabled, 1998.Google Scholar
  4. 4.
    Daeppen, J.-B., Smith, T. L., Danko, G. P., et al. Clinical correlates of cigarette smoking and nicotine dependence in alcohol dependent men and women. Submitted to Alcohol and Alcoholism.Google Scholar
  5. 5.
    Salloum, I. M., Daley, D. C., Cornelius, J. R., et al. Disproportionate lethality in psychiatric patients with concurrent alcohol and cocaine abuse. American Journal of Psychiatry 153:953–955, 1996.PubMedGoogle Scholar
  6. 6.
    Weiss, R. D., Martinez-Roga, J., & Hufford, C. The significance of a coexisting opioid use disorder in cocaine dependence. American Journal of Drug and Alcohol Abuse 22:173–184, 1996.PubMedCrossRefGoogle Scholar
  7. 7.
    Ross, J., Darke, S., & Hall, W. Transitions between routes of benzodiazepine administration among heroin users in Sydney. Addiction 92:697–705, 1997.PubMedCrossRefGoogle Scholar
  8. 8.
    Zukin, S. R., Sloboda, Z., & Javitt, D. C. Phencyclidine (PCP). In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 238–246.Google Scholar
  9. 9.
    Babe, K. S., & Serafin, W. E. Histamine, bradykinen, and their antagonists. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 581–600.Google Scholar
  10. 10.
    Bucholz, K. K., Hesselbrock, V. M., Heath, A. C., et al. Characterizing antisocial personality disorder symptoms in female and male relatives of alcoholics: A latent class analysis. Submitted to Addiction.Google Scholar
  11. 11.
    Myers, M. G., Stewart, D. G., & Brown, S. A. Progression from conduct disorder to antisocial personality disorder following treatment for adolescent substance abuse. American Journal of Psychiatry 155:479–485, 1998.PubMedGoogle Scholar
  12. 12.
    Kandel, D., & Yamaguchi, K. From beer to crack: Developmental patterns of drug involvement. American Journal of Public Health 53:851–855, 1993.CrossRefGoogle Scholar
  13. 13.
    American Psychiatric Association. The diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Press, 1994.Google Scholar
  14. 14.
    Schuckit, M. A., Daeppen, J.-B., Tipp, J. E., et al. The clinical course of alcohol-related problems in alcohol dependent and nonalcohol dependent drinking women and men. Journal of Studies on Alcohol 59:581–590, 1998.PubMedGoogle Scholar
  15. 15.
    Goodwin, D. W., & Guze, S. B. Psychiatric diagnosis (5th ed.). New York: Oxford University Press, 1996.Google Scholar
  16. 16.
    Holdcraft, L. C., Iacono, W. G., & McGue, M. K. Antisocial personality disorder and depression in relation to alcoholism: A community-based sample. Journal of Studies on Alcohol 59:222–226, 1998.PubMedGoogle Scholar
  17. 17.
    Vaillant, G. Evidence that type I/type II dichotomy in alcoholism must be reexamined. Addiction 89:1049–1057, 1994.PubMedCrossRefGoogle Scholar
  18. 18.
    Morrison, J., & Wickersham, P. Physicians disciplined by a state medical board. Journal of the American Medical Association 279:1889–1893, 1998.PubMedCrossRefGoogle Scholar
  19. 19.
    Tanda, G., Pontieri, F. E., & DiChiara, G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common u 1 opioid receptor mechanism. Science 276: 2048–2050, 1997.PubMedCrossRefGoogle Scholar
  20. 20.
    Tanaka, F., Shiratori, Y., Yokosuka, O., et al. Polymorphism of alcohol-metabolizing genes affects drinking behavior and alcoholic liver disease in Japanese men. Alcoholism: Clinical and Experimental Research 21:596–601, 1997CrossRefGoogle Scholar
  21. 21.
    Cowley, D. S., Roy-Byrne, P. P., Greenblatt, D. J., et al. Effect of diazepam on plasma γ-aminobutyric acid in sons of alcoholic fathers. Alcoholism: Clinical and Experimental Research 20:343–347, 1996.CrossRefGoogle Scholar
  22. 22.
    Hoffman, P. L., & Tabakoff, B. Alcohol dependence: A commentary on mechanisms. Alcohol and Alcoholism 31:333–340, 1996.PubMedCrossRefGoogle Scholar
  23. 23.
    Schuckit, M. A., Mazzanti, C., Smith, T. L., et al. Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABAα6 receptors and the serotonin transporter in the level of response to alcohol: A pilot study. Biological Psychiatry 45:647–651, 1999.PubMedCrossRefGoogle Scholar
  24. 24.
    Parsian, A., & Cloninger, C. R. Human GABA-A receptor alpha 1 and alpha 3 subunits genes and alcoholism. Alcoholism: Clinical and Experimental Research 21:430–433, 1997.Google Scholar
  25. 25.
    Potokar, J., Coupland, N., Glue, P., et al. Flumazenil in alcohol withdrawal: a double-blind placebo-controlled study. Alchohol and Alcoholism 32:605–611, 1997.CrossRefGoogle Scholar
  26. 26.
    Koob, G. F., & Roberts, A. J. Brain reward circuits in alcoholism. CNS Spectrums 4:23–37, 1999.Google Scholar
  27. 27.
    June, H. L., Grey, C., Warren-Reese, C., et al. The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: Preclinical studies in ethanol-preferring and outbred Wistar rats. Alcoholism: Clinical and Experimental Research 22:2174–2185, 1998.Google Scholar
  28. 28.
    Sander, T., Gscheidel, N., Wendel, B., et al. Human-opioid receptor variation and alcohol dependence. Alcoholism: Clinical and Experimental Research 22:2108–2110, 1988.Google Scholar
  29. 29.
    Schuckit, M. A., & Smith, T. L. An 8-year follow-up of 450 sons of alcoholic and control subjects. Archives of General Psychiatry 53:202–210, 1996.PubMedCrossRefGoogle Scholar
  30. 30.
    Beirut, L. J., Dinwiddie, S. H., Begleiter, H., et al. Familial transmission of substance dependence: Alcohol, marijuana, cocaine, and habitual smoking. Archives of General Psychiatry 55:982–988, 1998.CrossRefGoogle Scholar
  31. 31.
    Joseph, H., & Appel, P. Alcohol and methadone treatment: Consequences for the patient and program. American Journal of Drug and Alcohol Abuse 11:37–53, 1985.PubMedCrossRefGoogle Scholar
  32. 32.
    Magura, S., Nwakeze, P. C., & Demsky, S. Pre-and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 93:51–60, 1998.PubMedCrossRefGoogle Scholar
  33. 33.
    Grinspoon, L., & Bakalar, J. B. Marihuana. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 199–206.Google Scholar
  34. 34.
    Modell, J. G., & Mountry, J. M. Drinking and flying. New England Journal of Medicine 323:455–461, 1990.PubMedCrossRefGoogle Scholar
  35. 35.
    Cherpitel, C. J. Alcohol and injuries resulting from violence: A review of emergency room studies. Addiction 59:157–165, 1994.CrossRefGoogle Scholar
  36. 36.
    Russell, J. M., Newman, S. C., & Bland, R. C. Drug abuse and dependence. Acta Psychiatrica Scandinavica Supplementum 376:54–62, 1994.PubMedCrossRefGoogle Scholar
  37. 37.
    Schuckit, M. A. Educating yourself about alcohol and drugs. New York: Plenum Publishing Co., 1998.Google Scholar
  38. 38.
    McCance-Katz, E. F., Kosten, T. R., & Jatlow, P. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone—A multiple-dose study. Biological Psychiatry 44:250–259, 1998.PubMedCrossRefGoogle Scholar
  39. 39.
    Reynaud, M., Petit, G., Potard, D., & Courty, P. Six deaths linked to concomitant use of buprenorphine and benzodiazepines. Addiction 93:1385–1392, 1998.PubMedCrossRefGoogle Scholar
  40. 40.
    Robins, L. N. Vietnam veterans’ rapid recovery from heroin addiction: A fluke or normal expectation? Addiction 88:1041–1054, 1993.PubMedCrossRefGoogle Scholar
  41. 41.
    Albanese, M. J., Bartel, R. L., Bruno, R. E., et al. Comparisons of measures used to determine substance abuse in an inpatient psychiatric population. American Journal of Psychiatry 151:1077–1078, 1994.PubMedGoogle Scholar
  42. 42.
    Weinbroum, A. A., Flaishon, R., Sorkine, P., et al. A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose. Drug Safety 17:181–196, 1997.PubMedCrossRefGoogle Scholar
  43. 43.
    Atkinson, J. H., Slater, M. A., Patterson, T. L., et al. Prevalence, onset, and risk of psychiatric disorders in men with chronic low back pain: A controlled study. Pain 45:111–121, 1991.PubMedCrossRefGoogle Scholar
  44. 44.
    Hubbard, J. R., Smith-Everett, A., & Khan, M. A. Alcohol and drug abuse in patients with physical disabilities. American Journal of Drug and Alcohol Abuse 22:215–231, 1996.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Marc A. Schuckit
    • 1
  1. 1.University of California Medical School and Veterans Affairs San Diego Healthcare SystemSan DiegoUSA

Personalised recommendations